Glass Lewis urges Medivation shareholders to support current board

(Reuters) – Medivation Inc said shareholder advisory firm Glass Lewis & Co has recommended the cancer drug maker’s stockholders to not support Sanofi SA’s efforts to replace the company’s board…

Leave a Reply

Read the original at Reuters: Deals.